Company intelligence
MyOme
Empowering individuals to take control of their health through actionable genomic insights.
Biotechnology Research
Palo Alto, US
97 employees
2 public signals
About MyOme
Using whole genome sequencing and state-of-the-art bioinformatics, MyOme analyzes a single patient sample to produce comprehensive and clinically actionable reports that allow patients and their providers to make personalized lifestyle, prevention, and treatment choices.
Verified activity
Signals from MyOme
2 published signals
Presence & Recognition
MyOme is hosting a roundtable discussion on the updated 2026 ACC/AHA Dyslipidemia Guidelines and their implications for cardiovascular risk assessment with experts Akl Fahed, MD, MPH, and Michael Levin, MD.
Reported by MyOme
Presence & Recognition
MyOme hosted a roundtable discussion on the updated 2026 ACC/AHA Dyslipidemia Guidelines moderated by Akash Kumar MD, PhD, featuring cardiology experts Akl Fahed, MD, MPH, and Michael Levin, MD.
Reported by MyOme